Artwork

Contenuto fornito da MTPConnect. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da MTPConnect o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Player FM - App Podcast
Vai offline con l'app Player FM !

Recce Scouts New Synthetic Anti-Infectives to Overcome Resistance

36:09
 
Condividi
 

Manage episode 307778345 series 3009792
Contenuto fornito da MTPConnect. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da MTPConnect o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.

It’s World Antimicrobial Awareness Week 2021 and we are shining a light on Australia’s expertise and innovations to fight superbugs.

In this episode we catch up with Recce Pharmaceuticals, a company out of Western Australia that is pioneering the development and commercialisation of a new class of synthetic anti-infectives designed to overcome resistance. Its lead compound is the only synthetic polymer and sepsis drug candidate in development, as listed in the Pew Charitable Trusts Global New Antibiotics in Development Pipeline and has been awarded the US regulator’s Fast Track Designation under the GAIN Act.

Recce Pharmaceuticals’ Chief Executive Officer James Graham, joins the podcast from the United States after attending the World Antimicrobial Resistance Congress in Washington DC.

Joining host Caroline Duell is Andrew Bowskill, MTPConnect’s Director of Stakeholder Engagement for Queensland and the co-chair of AAMRNet, Australia’s first industry led, multi-stakeholder Antimicrobial Resistance Network, established and operated by MTPConnect.

  continue reading

169 episodi

Artwork
iconCondividi
 
Manage episode 307778345 series 3009792
Contenuto fornito da MTPConnect. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da MTPConnect o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.

It’s World Antimicrobial Awareness Week 2021 and we are shining a light on Australia’s expertise and innovations to fight superbugs.

In this episode we catch up with Recce Pharmaceuticals, a company out of Western Australia that is pioneering the development and commercialisation of a new class of synthetic anti-infectives designed to overcome resistance. Its lead compound is the only synthetic polymer and sepsis drug candidate in development, as listed in the Pew Charitable Trusts Global New Antibiotics in Development Pipeline and has been awarded the US regulator’s Fast Track Designation under the GAIN Act.

Recce Pharmaceuticals’ Chief Executive Officer James Graham, joins the podcast from the United States after attending the World Antimicrobial Resistance Congress in Washington DC.

Joining host Caroline Duell is Andrew Bowskill, MTPConnect’s Director of Stakeholder Engagement for Queensland and the co-chair of AAMRNet, Australia’s first industry led, multi-stakeholder Antimicrobial Resistance Network, established and operated by MTPConnect.

  continue reading

169 episodi

Όλα τα επεισόδια

×
 
Loading …

Benvenuto su Player FM!

Player FM ricerca sul web podcast di alta qualità che tu possa goderti adesso. È la migliore app di podcast e funziona su Android, iPhone e web. Registrati per sincronizzare le iscrizioni su tutti i tuoi dispositivi.

 

Guida rapida